SAN FRANCISCO, Jan. 6, 2016 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today the appointment of Ena Chan Cratsenburg as Senior Vice President, Consumer Sector. Ms. Cratsenburg will lead the expansion of Intrexon's programs to utilize innovative biologically-based applications for the development of products that improve the lives of consumers.
Ms. Cratsenburg brings to Intrexon over two decades experience in leading portfolio development and collaboration strategies for a number of consumer product businesses including cosmetics, flavors and fragrances, food and beverage, and nutritional health markets, as well as alternative fuels. Most recently Ms. Cratsenburg was Senior Vice President, Business Development with Evolva where she was responsible for identifying and evolving commercialization strategies for target businesses as well as successfully leading the development and negotiations of commercial partnerships. Prior to Evolva, she was Vice President of Business Development for Amyris, where she executed a number of strategic deals around emerging technologies for renewable ingredients. Ms. Cratsenburg also held business development roles at Pixar Animation Studios and BP plc. She holds an M.B.A. from the Kellogg Graduate School of Management of Northwestern University and a B.S. in Chemical Engineering from the University of Illinois.
Intrexon's Chairman and Chief Executive Officer Randal J. Kirk commented, "Ena's creativity and entrepreneurial spirit along with her proven track record of creating productive partnerships with leading international companies will well serve Intrexon. Her ability to turn innovative ideas into successful business strategies will help us grow our consumer-focused programs and enter into new markets that are just beginning to appreciate the potential of synthetic biology."
"I am thrilled to be joining the talented Intrexon team," Ms. Cratsenburg added. "Intrexon's portfolio of innovative technologies is transforming the way biologically-based products touch our lives. I am honored to lead the Consumer Sector and expand that transformation into products that benefit consumers, drive continued growth for the company and further enhance shareholder value."
About Intrexon Corporation
Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet. The Company's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com.
Intrexon, Powering the Bioindustrial Revolution with Better DNA, and Better DNA are trademarks of Intrexon and/or its affiliates. Other names may be trademarks of their respective owners.
Safe Harbor Statement
Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.
For more information contact:
Marie Rossi, Ph.D.
Senior Manager, Technical Communications
Tel: +1 (301) 556-9850
Vice President, Investor Relations
Tel: +1 (561) 410-7052
SOURCE Intrexon Corporation